Lopinavir (CAS 192725-17-0) Antiviral

Lopinavir (CAS 192725-17-0) is a high-purity antiviral API with potent inhibitory effects on viral replication. Manufactured under strict quality control standards, it features exceptional molecular stability and bioactivity, ensuring reliable performance in pharmaceutical formulations. As a key protease inhibitor, it targets critical viral replication processes, making it a valuable ingredient for developing antiviral medications.

Suitable for pharmaceutical R&D, drug manufacturing, and related biotech applications, this API offers a trusted solution for addressing viral infections. It meets global pharmacopoeia requirements, guaranteeing consistency and safety in every batch. For businesses and researchers seeking a high-quality, clinically validated antiviral ingredient, Lopinavir stands out as a cost-effective and performance-driven choice to support the development of effective therapeutic solutions.